[Invasive meningococcal disease--management and treatment].
Invasive meningococcal disease is life threatening disease and in fulminant cases mortality rate may be as high as 70%. Rapid introduction of treatment and monitoring on intensive care unit is crucial for prognosis. The understanding of patomechanism responsible for sepsis development allow to introduce supportive treatment including glicocorticoids and recombinant human activated protein C. Very important is suitable prophylaxis among risk groups with, additional considering vaccination in the case of infection caused by A, C, Y, W-135 serogroups.
Klinika Chorób Zakaźnych Collegium Medicum Uniwersytetu Jagiellońskiego.
Aleksander
A
Garlicki
Monika
M
Bociqga-Jasik
Anna
A
Kalinowska-Nowak
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D004196:Disease Outbreaks / Q000517:prevention & control*; D006293:Health Promotion / Q000458:organization & administration; D006801:Humans; D008585:Meningitis, Meningococcal / Q000453:epidemiology / Q000517:prevention & control; D008589:Meningococcal Infections / Q000453:epidemiology* / Q000517:prevention & control*; D022401:Meningococcal Vaccines / Q000627:therapeutic use*; D010353:Patient Education as Topic; D011322:Primary Prevention / Q000379:methods; D018570:Risk Assessment; D012307:Risk Factors
D000900:Anti-Bacterial Agents; D022401:Meningococcal Vaccines